ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,147 | -91.0% | 1,911 | -91.9% | 0.00% | – |
| Q1 2023 | $79,448 | +401.3% | 23,716 | +619.8% | 0.00% | – |
| Q4 2022 | $15,848 | -75.2% | 3,295 | -70.8% | 0.00% | – |
| Q3 2022 | $64,000 | +357.1% | 11,267 | +468.8% | 0.00% | – |
| Q2 2022 | $14,000 | -92.5% | 1,981 | -92.3% | 0.00% | – |
| Q1 2022 | $186,000 | -22.8% | 25,795 | -4.4% | 0.00% | – |
| Q4 2021 | $241,000 | – | 26,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |